In ovarian cancer, the CAF-derived Holliday Junction Recognition Protein (HJURP) enhances glutamine metabolism and tricarboxylic acid (TCA) cycle activity, facilitating resistance to doxorubicin [142]. This evidence concerns the gene HJURP and ovarian carcinoma.